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The viral disease named COVID-19 caused by family coronavirus is one of the biggest outbreaks reported on December 31, 2019, when China 
reported to the World Health Organisation (WHO) of a cluster of cases of pneumonia and lungs related ailments due to some unknown causative 
agent in Wuhan City in Hubei Province. The panic grew more when the disease spread recorded in Provinces of China, and now the problem 
has engulfed all the developed and developing nations of the world. The WHO has now declared it a major pandemic. Origin of virus and its 
evolutionary history can solve the mystery of this international pandemic outbreak. In the present review, various scenarios are discussed in 
reference to its origin and its rate of reproducibility in the mammals.
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IntroductIon
The outbreak of COVID-19 (Coronavirus Disease 2019) has brought 
the world to a stalemate, exposing our vulnerability to these 
invisible enemies and has invariably affected the whole world’s 
economy, in a way that for the first time, price of an oil barrel 
dropped below US $0 recently. Posing a great threat to human 
lives, the disease has now engulfed most of the developed nations, 
with USA being the most badly hit country both in terms of positive 
cases and deaths. Unfortunately, India hasn’t been untouched 
by this lethal disease and is taking all possible health measures 
amidst a 40-day long national lockdown to avoid the benchmarks 
of mortality established by other countries like Italy, Spain, China, 
France, UK, and USA. According to reports, aged people and those 
with a weaker immune system are more prone to this disease and 
do certainly qualify as easy prey to COVID-19. To date, a range of 
quick tools and techniques have been discovered and implemented 
for rapid detection of viral disease by numerous established labs. 
Still, the way to find an effective cure for this deadly disease looks 
uncertain in the near future. The genome size of this coronavirus 
and complexity of its origin has added difficulty in designing its 
accurate drug. The recently published news and articles claimed 
that it was genetically engineered by a well-established laboratory, 
but the variability in genetic makeup and relevance to its evolution 
points to the evidence of it being a modified version of coronavirus 
family with high affinity towards mammalian cells. Few scenarios 
related to its origin, transmission and binding to immune system 
probabilities have been discussed subsequently.
The structure and conformational pattern of coronavirus-2 
exhibits its complexity and raises concerns of researchers towards 
its zoonotic nature. To extract facts, available online platforms were 
accessed using various keywords viz. SARS, coronavirus, COVID-19, 
etc. and numerous reviews related to the spreading of disease and 
its historical trends were collected.  The data collected suggests its 
adaptability against humans.[1,2] Also, the evolutionary pattern of 
its origin displays a variety of facts about the novelty of this virus. 
Moreover, most of the research carried out pertains to case studies 
of different COVID-19 patients in affected countries. 
Falling in the criteria of life-threatening viral diseases and gaining 
much importance due to its higher rate of transferability has made it 
a great matter of concern for humankind. Today, every researcher is 
aware of the fact that coronavirus-2 has evolved as a better version 
of its family with a higher transferability rate among humans. The 
statement can be justified as the susceptibility of human exposure 
to disease depends upon the basic transferability and incubation 
period of disease-causing agents, which is a virus possessing RNA 
as genetic material. In concurrence of that the central concept of 
disease epidemiology ponders around the reproduction number of 
COVID-19, which indicates the risk of an infectious agent with regards 
to its spread. Various mathematically derived estimates were used 
to find out the basic reproduction number, which falls within the 
range produced by the statistical and stochastic estimates denoted 
as R0(R-naught). Here, R0 is an indication of the transmissibility of a 
virus, representing the average number of new infections generated 
by an infectious person, who can be asymptomatic (if showing 
symptoms) or silent spreader (if not showing symptoms but serving 
as a carrier and spreader of a virus) in a totally native population. 
For R0 >1, the number infected is likely to increase, and for R0 <1, 
the transmission is likely to die out.[3] As per reports, the range of R0 
value for severe acute respiratory syndrome (SARS) was between 2 
and 5, which is similar to the range of the mean R0 for COVID -19. As 
the region of exposure was same for both the viral diseases, having 
similar R0 values, despite the heightened public awareness with 
impactful, impressive and strong interventional control measures, 
COVID-19 has already been more widespread than SARS till date 
and has taken over one lakh lives so far, indicating it may be more 
transmissible and dangerous.[4] Based on these considerations, R0 
for COVID-19 is expected to be more than 2–3. The justification of 
the statement lies with the study revealed by doctors, as a patient 
with no symptoms became the carrier and spreader of disease to its 
family in China. The reports claimed that a familial cluster in Anyang, 
China tested COVID-19 positive after interacting with one of their 
family members, an asymptotic carrier who came back from Wuhan. 
These facts and sequence of events further exacerbate the fact that 
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the coronavirus 2 was transmitted by that particular asymptomatic 
carrier to its family.[5]
As far as the theories are concerned, various scenarios can be 
concluded by following the online published researches. Many 
studies showed collinearity of COVID-19 to the other outbreaks, 
such as Middle East Respiratory Syndrome (MERS), believed to 
be developed from camels and SARS (Severe Acute Respiratory 
Syndrome), which claimed to be sharing the genome origin from 
cat-like civets.[6] Whereas, the genomic data of the coronavirus 2 
responsible for COVID-19 confirms that the characteristic feature of 
its spike-like protein structure consists of some unique adaptations 
for disease cause. One of these adaptations provides special ability 
to this coronavirus to bind onto a specific protein on human cells 
called angiotensin-converting enzyme (ACE-2).[7] The same can 
be cited as the first scenario of coronavirus-2. The scientists and 
researchers claimed that coronavirus is evolved and mutated to bind 
to diverse systems of organisms believed to be originated from bats 
or pangolins. The spike proteins of COVID-19 mutated to bind to 
molecules, similar in the structure of the human ACE2 protein, lead 
to the distribution of infection in human cells. A related coronavirus 
that causes SARS in humans also seeks out ACE2, supporting their 
common binding pattern to the ACE2.
But on the other hand, existing computer models predicted 
that the new coronavirus would not bind to ACE2 like the SARS virus 
and has a better binding pattern than any other virus of its family. 
This is due to the pattern of natural selection on ACE2 enzyme that 
enables the virus to take advantage of a previously unidentified 
alternate binding site present, thereby infecting the human body 
dangerously. Conclusion, as suggested by the researchers, was that 
the above mentioned could be strong evidence that this virus is 
not a result of purposeful lab manipulation. To further establish 
this fact, the bioinformatic prediction tool suggests that evidence 
for an alternate binding site with the present conformation of spike 
protein can never be chosen by any bioengineer. 
The second scenario is that the coronavirus 2 transmitted from 
animals to humans before it became capable of causing human 
disease. Its pattern of infection and similarity to other viral species 
shows that it has resulted from gradual evolutionary changes over 
decades by natural means of genetic engineering or mutation and 
thus, gained the ability to spread from human-to-human and cause 
serious, often life-threatening situations.
In the third scenario, its transmission from human to animal 
was reported in New York, wherein felines showed COVID-19 like 
symptoms after getting the infection from their human caretakers, 
showing that it has the reverse of zoonotic mode as well. This case 
suggests that the adaptability of this virus is not limited to humans 
only, and other animal species may also be a threat in time to come. 
Its fast reproduction and efficiency towards the diverse fauna 
on earth highlight that this matter is of deep concern as no firm 
medication has been reported so far.
In such difficult times research is and should always be incessant 
and in the right direction. The importance of next-generation 
sequencing using integrated approaches is the only tool to 
accelerate disease detection protocols and drug designing. Certain 
researchers claim that using CRISPR technology is more useful 
in detection and cure. Cas13 based tools for transcript tiling and 
permutation screening in mammalian cells have also been claimed 
to be useful for the detection of COVID-19. The study reported 
that there is an identification of information for more than 24,000 
RNA-targeting guides, and the use of an optimized Cas13 screening 
system to target non-coding RNAs will be useful like the technology 
generated in the USA.[8] This can greatly expand the CRISPR toolbox 
for forwarding genetic and transcriptomics screens.
Whereas, recent progress in research has also claimed that the 
nutritional status of each infected patient is a matter of concern 
and should be evaluated before the administration of general 
treatments. In addition, convalescent plasma which has now 
opened the doors as a therapy for this COVID -19 can be given to 
patients post deliberate tests.[3]
The keynote should be underlined for the layman as addressed 
by Dr. Tedros Adhanom Ghebreyesus, the director general of the 
WHO “Pandemic is not a word to use lightly or carelessly”, hence, 
until the efforts are under process, there is an urge to repel this 
disease which can be achieved by observing good hygiene and 
sanitation, practicing frequent social distancing, cooperating with 
law makers and most importantly encouraging and supporting the 
efforts of dedicated health-care professionals and researchers who 
are working endlessly and tirelessly against the pandemic for well-
being of humankind. 
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